Publications

The Journal of experimental medicine

MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer.

06-11-2023

Life science alliance

Grp78 is required for intestinal Kras-dependent glycolysis proliferation and adenomagenesis.

01-11-2023

Journal of pharmaceutical and biomedical analysis

Validated LC-MS/MS method for simultaneous quantification of KRAS^G12C inhibitor sotorasib and its major circulating metabolite (M24) in mouse matrices and its application in a mouse pharmacokinetic study.

25-10-2023

Cancer

Depression, anxiety, and the risk of cancer: An individual participant data meta-analysis.

15-10-2023

European journal of cancer (Oxford, England : 1990)

Active surveillance versus treatment in low-risk DCIS: Women's preferences in the LORD-trial.

01-10-2023

Climacteric : the journal of the International Menopause Society

Impact of risk-reducing salpingo-oophorectomy on lipid determinants, HbA1c and CRP.

01-10-2023

Obesity surgery

Impact of Bariatric Surgery in the Short and Long Term: A Need for Time-Dependent Dosing of Drugs.

01-10-2023

International journal of radiation oncology, biology, physics

Coverage of Lateral Lymph Nodes in Rectal Cancer Patients with Routine Radiation Therapy Practice and Associated Locoregional Recurrence Rates.

01-10-2023

Journal of internal medicine

Precision cancer medicine: Concepts, current practice, and future developments.

01-10-2023

Patient education and counseling

What makes patient involvement work? Lessons learned from a qualitative study in adolescents and young adults with cancer.

01-10-2023

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

High accumulation of nivolumab in human breast milk: A case report.

01-10-2023

Gut

An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles.

01-10-2023

Abdominal radiology (New York)

Predicting response to chemoradiotherapy in rectal cancer via visual morphologic assessment and staging on baseline MRI: a multicenter and multireader study.

01-10-2023

British journal of clinical pharmacology

Optimizing carboplatin dosing by an improved prediction of carboplatin clearance using a CT-enhanced estimate of renal function.

01-10-2023

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Pharmacokinetics of the KRAS^G12C inhibitor adagrasib is limited by CYP3A and ABCB1, and influenced by binding to mouse plasma carboxylesterase 1c.

01-10-2023

International journal of cancer

Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials.

01-10-2023

Breast (Edinburgh, Scotland)

Agreement on risk assessment and chemotherapy recommendations among breast cancer specialists: A survey within the MINDACT cohort.

01-10-2023

DNA repair

Live cell transcription-coupled nucleotide excision repair dynamics revisited.

01-10-2023

Therapeutic drug monitoring

Potential of Mesalazine Therapeutic Drug Monitoring by Measuring Fecal Excretion in Patients With Ulcerative Colitis.

01-10-2023

Journal of empirical research on human research ethics : JERHRE

Health Research with Data in a Time of Privacy: Which Information do Patients Want?

01-10-2023

Frontiers in oncology

Size and depth of residual tumor after neoadjuvant chemoradiotherapy in rectal cancer - implications for the development of new imaging modalities for response assessment.

22-09-2023

Blood advances

International validation of a health-related quality of life questionnaire for Hodgkin Lymphoma: the EORTC QLQ-HL27.

22-09-2023

Cell research

LICOB: a powerful organoid platform for drug discovery.

20-09-2023

Frontiers in immunology

The bladder cancer immune micro-environment in the context of response to immune checkpoint inhibition.

20-09-2023

The Journal of antimicrobial chemotherapy

Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis.

20-09-2023

Cell reports

Perturbations in 3D genome organization can promote acquired drug resistance.

20-09-2023

Frontiers in genetics

Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

18-09-2023

International journal of radiation oncology, biology, physics

Risk Modeling for Individualization of the FLAME Focal Boost Approach in External Beam Radiation Therapy for Patients With Localized Prostate Cancer.

18-09-2023

Frontiers in oncology

Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial.

15-09-2023

Clinical cancer research : an official journal of the American Association for Cancer Research

Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features.

15-09-2023

PloS one

Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer.

14-09-2023

Journal of patient-reported outcomes

Health-related quality of life of Adolescent and Young Adult Cancer Survivors before and during the COVID-19 pandemic: longitudinal improvements on social functioning and fatigue.

13-09-2023

ESMO open

Authors' reply-Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not.

13-09-2023

Paediatric drugs

Azacitidine (Vidaza^®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015).

11-09-2023

The Lancet. Oncology

Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial.

11-09-2023

The EMBO journal

Pioneer activity distinguishes activating from non-activating SOX2 binding sites.

11-09-2023

Cancer discovery

Transposable elements are co-opted as oncogenic regulatory elements by lineage-specific transcription factors in prostate cancer.

11-09-2023

NPJ breast cancer

High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial.

09-09-2023

Urologic oncology

Patient-reported outcome measures compared to clinician reported outcomes regarding incontinence and erectile dysfunction in localized prostate carcinoma after robot assisted radical prostatectomy: Impact on management.

08-09-2023

BJOG : an international journal of obstetrics and gynaecology

Author reply.

08-09-2023

Physics in medicine and biology

An improved camera model for oblique-viewing laparoscopes: high reprojection accuracy independent of telescope rotation.

08-09-2023

BMC medical research methodology

Correction: A scoping review of statistical methods in studies of biomarker-related treatment heterogeneity for breast cancer.

08-09-2023

Annals of behavioral medicine : a publication of the Society of Behavioral Medicine

Using the Behavior Change Wheel to Identify and Understand Key Facilitators and Barriers for Lifestyle Care for Postmenopausal Breast Cancer Survivors: A Delphi-Study.

06-09-2023

Cancer discovery

Biomarker-Driven Personalization of Neoadjuvant Immunotherapy in Melanoma.

05-09-2023

Cancers

DCIS and LCIS: Are the Risk Factors for Developing In Situ Breast Cancer Different?

02-09-2023

Cancer

International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).

01-09-2023

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Updated normative data for the EORTC QLQ-C30 in the general Dutch population by age and sex: a cross-sectional panel research study.

01-09-2023

Annals of surgical oncology

ASO Visual Abstract: Oncological Outcome After Lymph Node Dissection for Cutaneous Squamous Cell Carcinoma.

01-09-2023

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Recommendations for improved reproducibility of ADC derivation on behalf of the Elekta MRI-linac consortium image analysis working group.

01-09-2023

Clinical advances in hematology & oncology : H&O

Repurposing drugs in oncology.

01-09-2023

MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer.

Grp78 is required for intestinal Kras-dependent glycolysis proliferation and adenomagenesis.

Validated LC-MS/MS method for simultaneous quantification of KRASG12C inhibitor sotorasib and its major circulating metabolite (M24) in mouse matrices and its application in a mouse pharmacokinetic study.

Depression, anxiety, and the risk of cancer: An individual participant data meta-analysis.

Active surveillance versus treatment in low-risk DCIS: Women's preferences in the LORD-trial.

Impact of risk-reducing salpingo-oophorectomy on lipid determinants, HbA1c and CRP.

Impact of Bariatric Surgery in the Short and Long Term: A Need for Time-Dependent Dosing of Drugs.

Coverage of Lateral Lymph Nodes in Rectal Cancer Patients with Routine Radiation Therapy Practice and Associated Locoregional Recurrence Rates.

Precision cancer medicine: Concepts, current practice, and future developments.

What makes patient involvement work? Lessons learned from a qualitative study in adolescents and young adults with cancer.

High accumulation of nivolumab in human breast milk: A case report.

An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles.

Predicting response to chemoradiotherapy in rectal cancer via visual morphologic assessment and staging on baseline MRI: a multicenter and multireader study.

Optimizing carboplatin dosing by an improved prediction of carboplatin clearance using a CT-enhanced estimate of renal function.

Pharmacokinetics of the KRASG12C inhibitor adagrasib is limited by CYP3A and ABCB1, and influenced by binding to mouse plasma carboxylesterase 1c.

Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials.

Agreement on risk assessment and chemotherapy recommendations among breast cancer specialists: A survey within the MINDACT cohort.

Live cell transcription-coupled nucleotide excision repair dynamics revisited.

Potential of Mesalazine Therapeutic Drug Monitoring by Measuring Fecal Excretion in Patients With Ulcerative Colitis.

Health Research with Data in a Time of Privacy: Which Information do Patients Want?

Size and depth of residual tumor after neoadjuvant chemoradiotherapy in rectal cancer - implications for the development of new imaging modalities for response assessment.

International validation of a health-related quality of life questionnaire for Hodgkin Lymphoma: the EORTC QLQ-HL27.

LICOB: a powerful organoid platform for drug discovery.

The bladder cancer immune micro-environment in the context of response to immune checkpoint inhibition.

Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis.

Perturbations in 3D genome organization can promote acquired drug resistance.

Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

Risk Modeling for Individualization of the FLAME Focal Boost Approach in External Beam Radiation Therapy for Patients With Localized Prostate Cancer.

Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial.

Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features.

Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer.

Health-related quality of life of Adolescent and Young Adult Cancer Survivors before and during the COVID-19 pandemic: longitudinal improvements on social functioning and fatigue.

Authors' reply-Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not.

Azacitidine (Vidaza®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015).

Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial.

Pioneer activity distinguishes activating from non-activating SOX2 binding sites.

Transposable elements are co-opted as oncogenic regulatory elements by lineage-specific transcription factors in prostate cancer.

High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial.

Patient-reported outcome measures compared to clinician reported outcomes regarding incontinence and erectile dysfunction in localized prostate carcinoma after robot assisted radical prostatectomy: Impact on management.

Author reply.

An improved camera model for oblique-viewing laparoscopes: high reprojection accuracy independent of telescope rotation.

Correction: A scoping review of statistical methods in studies of biomarker-related treatment heterogeneity for breast cancer.

Using the Behavior Change Wheel to Identify and Understand Key Facilitators and Barriers for Lifestyle Care for Postmenopausal Breast Cancer Survivors: A Delphi-Study.

Biomarker-Driven Personalization of Neoadjuvant Immunotherapy in Melanoma.

DCIS and LCIS: Are the Risk Factors for Developing In Situ Breast Cancer Different?

International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).

Updated normative data for the EORTC QLQ-C30 in the general Dutch population by age and sex: a cross-sectional panel research study.

ASO Visual Abstract: Oncological Outcome After Lymph Node Dissection for Cutaneous Squamous Cell Carcinoma.

Recommendations for improved reproducibility of ADC derivation on behalf of the Elekta MRI-linac consortium image analysis working group.

Repurposing drugs in oncology.

This site uses cookies

Validated LC-MS/MS method for simultaneous quantification of KRAS^G12C inhibitor sotorasib and its major circulating metabolite (M24) in mouse matrices and its application in a mouse pharmacokinetic study.

Pharmacokinetics of the KRAS^G12C inhibitor adagrasib is limited by CYP3A and ABCB1, and influenced by binding to mouse plasma carboxylesterase 1c.

Azacitidine (Vidaza^®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015).